Abstract:Toll-like receptors (TLRs) belong to the Toll–interleukin 1 receptor superfamily, which is defined by a common intracellular Toll-IL-1 receptor (TIR) domain. A group of TIR domain containing adaptors (MyD88, TIRAP, TRIF and TRAM), are differentially recruited to the Toll-IL-1 receptors, contributing to the specificity of signaling. The IL-1 mediated signaling pathway serves as a “prototype” for other family members. Genetic and biochemical studies reveal that IL-1R uses adaptor molecule MyD88 to mediate a very complex pathway, involving a cascade of kinases organized by multiple adapter molecules into signaling complexes, leading to activation of the transcription factor NFκB. Several Toll-like receptors utilize variations of the “prototype” pathway by employing different adaptor molecules. Double-stranded RNA triggered, TLR3-mediated signaling is independent of MyD88, IRAK4, and IRAK. The adapter molecule TRIF is utilized by TLR3 to mediate the activation of NFκB and IRF3. LPS-induced, TLR4-mediated signaling employs multiple TIR-domain containing adaptors, MyD88/TIRAP to mediate NFκB activation, TRIF/TRAM for IRF3 activation. Recent studies have also begun to unravel how these pathways are negatively regulated. SIGIRR (also known as TIR8), a member of TIR superfamily that does not activate the transcription factors NFκB and IRF3, instead negatively modulates responses. Cells from SIGIRR-null mice show enhanced activation in response to either IL-1 or certain Toll ligands. In addition to SIGIRR, several other negative regulators have been shown to inhibit the TIR signaling, including ST2, IRAKM, MyD88s, SOCS1, and Triad3A. The coordinated positive and negative regulation of the TIR signaling ensures the appropriate modulation of the innate and inflammatory responses

Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K

Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt

Tbk1, A Central Kinase In Innate Immune Sensing Of Nucleic Acids And Beyond

TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation

Modulation of Toll–interleukin 1 receptor mediated signaling

Imperative role of adaptor proteins in macrophage toll-like receptor signaling pathways

LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

TLR Signaling Pathways: Opportunities for Activation and Blockade in Pursuit of Therapy

The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications

Rethinking Toll-like receptor signalling

Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals

BCAP links IL-1R to the PI3K–mTOR pathway and regulates pathogenic Th17 cell differentiation

Protein phosphatases in TLR signaling

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Toll-like receptors in inflammation, infection and cancer

Toll-like receptor control of the adaptive immune responses

The Evolving Role of TRAFs in Mediating Inflammatory Responses

Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins

PI3K Isoforms in Cell Signalling and Innate Immune Cell Responses

Regulation of phospholipase C-gamma2 and phosphoinositide 3-kinase pathways by adaptor proteins in B lymphocytes